Extending from the work employing eNOS transfected EPCs for models of pulmonary disease and cardiac disease, our group is testing the effectiveness of human EPCs with and without eNOS transfection in a xenogenic model of kidney injury using immune deficient non-obese diabetic (NOD/SCID) mice. Here, NOS3 is linked to heart disorder.